 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/19/2023 |
$24.62 |
$24.67 |
$24.05 |
$24.44 |
1.85M | | 09/20/2023 |
$24.44 |
$24.95 |
$23.76 |
$23.79 |
1.39M | | 09/21/2023 |
$23.70 |
$23.95 |
$23.27 |
$23.40 |
1.62M | | 09/22/2023 |
$23.56 |
$23.74 |
$22.97 |
$23.56 |
1.70M | | 09/25/2023 |
$23.43 |
$23.60 |
$23.08 |
$23.29 |
1.78M |
|
|
| Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system disorders. Co. has a portfolio of product including its drug, NUPLAZID (pimavanserin), which has been approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. NUPLAZID is a selective serotonin inverse agonist/antagonist, targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. | |
|
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on September 19, 2023, ACAD opened at $24.62, traded as high as $24.67 and as low as $24.05, and closed at $24.44. Trading volume was a total of 1.85M shares. On September 20, 2023, ACAD opened at $24.44, traded as high as $24.95 and as low as $23.76, and closed at $23.79. Trading volume was a total of 1.39M shares. On September 21, 2023, ACAD opened at $23.70, traded as high as $23.95 and as low as $23.27, and closed at $23.40. Trading volume was a total of 1.62M shares. On September 22, 2023, ACAD opened at $23.56, traded as high as $23.74 and as low as $22.97, and closed at $23.56. Trading volume was a total of 1.70M shares. On September 25, 2023, ACAD opened at $23.43, traded as high as $23.60 and as low as $23.08, and closed at $23.29. Trading volume was a total of 1.78M shares.
ACAD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/27/2013 |
|
| End date: |
09/25/2023 |
|
| Start price/share: |
$27.03 |
|
| End price/share: |
$23.29 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-13.84% |
|
| Average Annual Total Return: |
-1.48% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,614.78 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 09/19/2023 | $24.44 | | 09/20/2023 | $23.79 | | 09/21/2023 | $23.40 | | 09/22/2023 | $23.56 | | 09/25/2023 | $23.29 |
|
|
Free ACAD Email Alerts:
